Health TrialsbyHealthPanel

UNC Tobacco Convenience Store

ConditionHealth Behavior
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of North Carolina, Chapel Hill

About this trial

The main purpose of this trial is to evaluate the impact of a menthol cigarette ban accompanied by a quit smoking campaign on tobacco purchasing behavior. Investigators will conduct a randomized clinical trial with \~1,185 US adults (ages 21+ years) who currently smoke menthol cigarettes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Are ages 21 years and older

Smoke cigarettes currently (i.e. currently smoke some days or every day and have smoked at least 100 cigarettes in their lifetime)

Smoke menthol cigarettes

Purchased menthol cigarettes in a store in the past month

Disqualifiers

Are pregnant

Are breastfeeding

Enrolled currently in another research study about quitting smoking

Trial design

Design model

Parallel

Treatments tested in this trial

  • Menthol ban + campaign

    Behavioral

    Menthol cigarettes and flavored little cigars and cigarillos will not be available for purchase in the store. Participants will receive quit smoking campaign ads via text message. These ads will also be displayed inside the store during the shopping tasks.

  • Menthol ban

    Behavioral

    Menthol cigarettes and flavored little cigars and cigarillos will not be available for purchase in the store. Participants will receive control ads about a neutral topic (i.e., password security) via text message. These ads will also be displayed inside the store during the shopping tasks.

  • Control

    Behavioral

    Menthol cigarettes and flavored little cigars and cigarillos will be available for purchase in the store. Participants will receive control ads about a neutral topic (i.e., password security) via text message. These ads will also be displayed inside the store during the shopping tasks.

Treatment groups

1,185 Participants
are divided into 3 treatment groups
Group A: Menthol ban + campaignExperimental treatment 1 intervention
Group B: Menthol banExperimental treatment 1 intervention
Group C: ControlOther 1 intervention

Trial outcomes

Primary outcomes

1

Purchasing any combustible tobacco products

Measured using purchase data for combustible tobacco products, defined as any cigarettes or little cigars and cigarillos. Response options are "No" (coded as 0) and "Yes" (coded as 1).

Time frame
Assessed 2 times approximately 1-week apart, starting on the day of enrollment.

Secondary outcomes

1

Expenditures on combustible tobacco products

Measured using purchase data for combustible tobacco products, defined as any cigarettes or little cigars and cigarillos. This measure is in US dollars, ranging from $0 to $70.

Time frame
Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
2

Purchasing any non-combustible tobacco products (substitution effects)

Measured using purchase data on whether participants bought any non-combustible tobacco products, defined as any e-cigarettes, smokeless tobacco, or nicotine pouches. Response options are "No" (coded as 0) and "Yes" (coded as 1).

Time frame
Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
3

Attempted to quit smoking

Measured using 1 survey item: "In the last week, did you stop smoking cigarettes for 1 day or longer because you were trying to quit smoking?" Response options are "No" coded as 0) and "Yes" (coded as 1).

Time frame
Assessed 1 time, approximately 1 week after enrollment.
4

Forgoing cigarette use

Measured using 2 survey items (e.g., " In the last week, how often have you stopped yourself from having a cigarette because you wanted to smoke less?"). The 5-point response scale ranges from "Never" coded as 0, to "10 or more times", coded as 10. Researchers will average responses to the 2 survey items to create a scale score. Higher scores indicate greater frequency of forgoing cigarettes.

Time frame
Assessed 1 time, approximately 1 week after enrollment.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of North Carolina, Chapel Hill

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

Food and Drug Administration (FDA)

Collaborator

Source ClinicalTrials.gov
Apply now